Familial paraganglioma-pheochromocytoma syndrome is a hereditary condition indicated by the presence of tumors called paragangliomas and/or pheochromocytomas. Paranganglioma tumors arise from bundles ...
The supplemental new drug application is based on data from the Phase 2 LITESPARK-015 trial.
Merck & Co. has won U.S. Food and Drug Administration priority review for its application seeking expanded use of its Welireg oral cancer drug in patients with rare tumors that form in and around the ...